- Exchange: Berlin
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Snapshot for AstraZeneca PLC (ZEGA)
| Open: | 40.710 | Day's Range: | 39.613 - 40.710 | Volume: | 0 |
|---|---|---|---|---|---|
| Previous Close: | 40.193 | 52wk Range: | 31.596 - 40.710 | 1-Yr Rtn: | +29.16% |
Key Statistics for ZEGA
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | 9.4124 |
| Relative P/E vs. DAX | - |
| Earnings Per Share (USD) (ttm) | - |
| Est. EPS (USD) (12/2013) | 5.4430 |
| Est. PEG Ratio | - |
| Market Cap (M EUR) | 0.00 |
| Shares Outstanding (M) | 0.00 |
| 30 Day Average Volume | 38 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | 7.09% |
| Cash Dividend (USD) | 1.9000 |
| Last Dividend | 02/13/2013 |
| 5 Year Dividend Growth | 10.34% |
| Next Earnings Announcement | 08/01/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for ZEGA
Company Profile & Key Executives for ZEGA
AstraZeneca PLC is a holding company. The Company, through its subsidiaries, researches, manufactures, and sells pharmaceutical and medical products. AstraZeneca focuses its operations on eight therapeutic areas: Gastrointestinal, Oncology, Cardiovascular, Respiratory, Central Nervous System, Pain Control, Anaesthesia, and Infection.
| Pascal SoriotChief Executive Officer | Simon Jonathan LowthChief Financial Officer |
| Katarina AgeborgChief Compliance Officer | Ruud DobberExec VP:Europe |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
ZEGA News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page